Sponsor

Indiana University

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Indiana University appears in 401 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials401
Recruiting shown40
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

60 shown
Enhancing Shared Decision-making to Guide Care for People With Dementia and DiabetesNCT05643144 · lead sponsor · 2026-09-29
RECRUITING
Prospective Study on Radiation Induced Cardiotoxicity Assessed By PET-CT for Locally Advanced Non-Small Cell Lung Cancer (NSCLC)NCT07761910 · lead sponsor · 2026-09-01
RECRUITING
Finding Immune Nascent Type 1 DiabetesNCT07663136 · lead sponsor · 2026-07-28
RECRUITING
MOCHA: Embedded Inpatient Mental Health Care for High-Risk Perinatal PatientsNCT07540585 · lead sponsor · 2026-07-15
RECRUITING
Imaging the Effects of Netarsudil (Rhopressa) on the Trabecular Meshwork in Glaucoma and Ocular HypertensionNCT07588152 · lead sponsor · 2026-06-05
RECRUITING
Miniaturized Breath-based Sensor for the Detection of Hypo- and HyperglycemiaNCT07696273 · lead sponsor · 2026-05-31
RECRUITING
Racial Disparities in the Expression of ParanoiaNCT07460453 · lead sponsor · 2026-04-13
RECRUITING
The Effects of Cognitive Behavioral Therapy on Insulin Resistance in People With HIVNCT07226128 · lead sponsor · 2026-04-10
RECRUITING
Safety and Efficacy of Adjunct Therapies in Adults With Type 1 Diabetes: Multicenter, Registry StudyNCT07676565 · lead sponsor · 2026-03-24
RECRUITING
Caring for Caregivers of Individuals With Alzheimer's DiseaseNCT07486037 · lead sponsor · 2026-03-01
RECRUITING
Drug Interaction Potential of Pro-Inflammatory ConditionsNCT07360938 · lead sponsor · 2025-11-01
RECRUITING
Palliative Care for People With HFNCT07356843 · lead sponsor · 2025-10-29
RECRUITING
SPARK Healthy SleepNCT07119268 · lead sponsor · 2025-10-24
RECRUITING
Monitoring Exhaled Breath to Noninvasively Detect Glycemic EventsNCT06893341 · lead sponsor · 2025-10-23
RECRUITING
Enhanced Mentor Mother Strategy for Pregnant and Postpartum Women Living With HIVNCT06999928 · lead sponsor · 2025-07-10
RECRUITING
New Approaches for the Diagnosis of Lymphoma and Multicentric Castleman DiseaseNCT07793006 · lead sponsor · 2025-03-17
RECRUITING
NearWave Optical Molecular MonitoringNCT06744465 · lead sponsor · 2025-03-07
RECRUITING
Ketone Ester And Salt (KEAS) in Older AdultsNCT06868719 · lead sponsor · 2025-03-06
RECRUITING
Evaluating Tolerability of ePUHRT With Brachytherapy BoostNCT06817668 · lead sponsor · 2025-03-05
RECRUITING
The Alama Project: Autism Outcomes and Neurobehavioral Markers in Young Children Born to Mothers With HIV in KenyaNCT06703125 · lead sponsor · 2025-02-11
RECRUITING
Nicotinic Acid for the Treatment of Alzheimer's DiseaseNCT06582706 · lead sponsor · 2024-12-19
RECRUITING
Leg Heat Therapy in Heart Failure With Preserved Ejection FractionNCT06388226 · lead sponsor · 2024-08-15
RECRUITING
Acoustic Waveform Respiratory EvaluationNCT06512064 · lead sponsor · 2024-07-23
RECRUITING
A Feasiblity Study of Green Activity Program for People Living With Memory ChallengesNCT06403345 · lead sponsor · 2024-07-17
RECRUITING
Lifestyle Interventions for the Treatment of Early Onset Alzheimer's Disease StudyNCT05573490 · lead sponsor · 2024-01-11
RECRUITING
rTMS to Target Neural Connectivity and Rumination in Treatment-Resistant DepressionNCT06511544 · lead sponsor · 2024-01-02
RECRUITING
ASCVD Management Using CCTA in Prostate Cancer Patients on ADTNCT05879913 · lead sponsor · 2023-12-15
RECRUITING
Increasing Equity in Lung Cancer ScreeningNCT06360822 · lead sponsor · 2023-12-01
RECRUITING
MIND Foods and Aerobic Training in Black Adults With HTNNCT06152614 · lead sponsor · 2023-11-28
RECRUITING
I-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related SymptomsNCT05733520 · lead sponsor · 2023-05-30
RECRUITING
Exercise in Metastatic Breast Cancer: EMBodyNCT05468034 · lead sponsor · 2023-04-26
RECRUITING
Delivering Food Resources & Kitchen Skills (FoRKS) to Adults With Food Insecurity and HypertensionNCT05856591 · lead sponsor · 2023-04-17
RECRUITING
Ketone Ester and Salt (KEAS) in Young AdultsNCT05545501 · lead sponsor · 2023-03-24
RECRUITING
Rapid Autopsy Protocol for Patients With Small Cell Lung CancerNCT05889546 · lead sponsor · 2022-08-31
RECRUITING
Intensive Glycemic Targets in Overweight and Obese Women With Gestational DiabetesNCT05124808 · lead sponsor · 2022-03-01
RECRUITING
Biomarker of Diabetic RetinopathyNCT05079399 · lead sponsor · 2022-01-01
RECRUITING
5HTP Regulation Of Asthma In ChildrenNCT04160910 · lead sponsor · 2021-02-11
RECRUITING
Measuring Adverse Pregnancy and Newborn Congenital OutcomesNCT04405700 · lead sponsor · 2020-09-29
RECRUITING
Pediatric Cardiomyopathy Mutation AnalysisNCT02432092 · lead sponsor · 2014-04-01
RECRUITING
Alzheimer's Disease Genetics StudyNCT00064870 · lead sponsor · 2002-06-01
RECRUITING
Virtual Communication in the Hospital: Impact on Patients and SurrogatesNCT05395039 · lead sponsor · 2027-03-31
WITHDRAWN
Effect Of Percutaneous Electrical Nerve Field Stimulation on Symptom Control/Nervous System Activity in Patients w/Diabetes Types 1/2NCT06783504 · lead sponsor · 2027-02-10
NOT_YET_RECRUITING
Efficacy and Safety of Slow Release Dehydroepiandrosterone (DHEA )NCT07179952 · lead sponsor · 2027-01-01
NOT_YET_RECRUITING
Cognitive and Behavioral Approaches to Reduce Binge Eating and Excess Weight in Adolescents (Online)NCT07856784 · lead sponsor · 2026-11-01
NOT_YET_RECRUITING
Supplementation of Gut-brain Axis (GLP-1)-Activating Carbohydrates for Increasing Satiety in Adolescents With ObesityNCT07823452 · lead sponsor · 2026-10-01
NOT_YET_RECRUITING
Pilot Study of Hydroxychloroquine for the Treatment of AIMSSNCT07825454 · lead sponsor · 2026-09-01
NOT_YET_RECRUITING
VICA: A Virtual Care Assistant for Dementia CaregiversNCT07779785 · lead sponsor · 2026-08-17
NOT_YET_RECRUITING
Lifestyle Interventions to Improve Glycemic Parameters and Reduce Gestational Diabetes in High-risk Pregnant IndividualsNCT06445270 · lead sponsor · 2026-08-01
WITHDRAWN
Automated, Assistive, Non-Contact Sleep Quality Monitor for Individuals With Alzheimer's DiseaseNCT06045988 · lead sponsor · 2026-07-01
NOT_YET_RECRUITING
Measurement of High Blood Pressure Using BoppliNCT07547917 · lead sponsor · 2026-04-30
ENROLLING_BY_INVITATION
Estimating the Impact of Obesity Medications on Clinical and Economic OutcomesNCT07640139 · lead sponsor · 2026-01-01
ENROLLING_BY_INVITATION
Smart Soft Contact Lenses for Monitoring GlaucomaNCT07224542 · lead sponsor · 2025-10-19
ENROLLING_BY_INVITATION
Promoting Aging and Thriving With HIVNCT07192419 · lead sponsor · 2025-10-17
ENROLLING_BY_INVITATION
Innovative Cognitive Impairment Case Finding and Engagement for Diverse Participation in Alzheimer's Disease Care, Treatment, And ResearchNCT07016178 · lead sponsor · 2025-10-13
COMPLETED
Pilot Randomized Clinical Trial of Informational Support Versus Spiritual CareNCT07176559 · lead sponsor · 2025-09-09
ACTIVE_NOT_RECRUITING
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot TrialNCT07119658 · lead sponsor · 2025-07-08
COMPLETED
CGM Dynamic Index for Predicting Prediabetes in Cystic FibrosisNCT06642610 · lead sponsor · 2025-06-15
COMPLETED
Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0NCT06823115 · lead sponsor · 2025-03-01
ENROLLING_BY_INVITATION
Evaluating iCare COMPASS as a Visual Field Diagnostic ToolNCT07765147 · lead sponsor · 2025-02-07
COMPLETED
Exercise as Maintenance Therapy in Advanced Lung CancerNCT06513663 · lead sponsor · 2024-10-15
TERMINATED

Drugs studied in this sponsor's trials

72 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Indiana University as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.
placebo15
capecitabine4
carboplatin3
paclitaxel3
pentoxifylline3
bevacizumab2
chlorthalidone2
cyclophosphamide2
placebo RxCUI 8375 · Lead sponsor in 14 linked trial(s) · 1 currently recruiting 15 trials capecitabine RxCUI 194000 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 4 trials carboplatin RxCUI 40048 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 3 trials paclitaxel RxCUI 56946 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 3 trials pentoxifylline RxCUI 8013 · Lead sponsor in 3 linked trial(s) · 0 currently recruiting 3 trials bevacizumab RxCUI 253337 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 2 trials chlorthalidone RxCUI 2409 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 2 trials cyclophosphamide RxCUI 3002 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 2 trials efavirenz RxCUI 195085 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 2 trials 5-hydroxytryptophan RxCUI 94 · Lead sponsor in 1 linked trial(s) · 1 currently recruiting 1 trial acarbose RxCUI 16681 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial acetylcysteine RxCUI 197 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial atazanavir RxCUI 343047 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial atenolol RxCUI 1202 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial Avastin RxCUI 337521 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial daclizumab RxCUI 190353 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial denosumab RxCUI 993449 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial dolutegravir 50 MG / rilpivirine 25 MG Oral Tablet [Juluca] RxCUI 1989506 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial donepezil RxCUI 135447 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial doxorubicin RxCUI 3639 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial dronabinol RxCUI 10402 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial duloxetine RxCUI 72625 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial durvalumab RxCUI 1919503 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial eflornithine RxCUI 569 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial

Sponsor roles

lead sponsor297
collaborator104
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.